Andrew Herxheimer

5.6k citations
156 papers · 3.5k indexed · h-index 36
Topics
Pharmaceutical industry and healthcare (16 papers)Pharmaceutical Economics and Policy (14 papers)Pharmaceutical Practices and Patient Outcomes (12 papers)

In The Last Decade

Andrew Herxheimer

147 papers receiving 3.1k citations

Peers

Andrew Herxheimer
Comparison fields: 5 of 181
  • Public Health, Environmental and Occupational Health 625
  • General Health Professions 466
  • Economics and Econometrics 392
  • Pediatrics, Perinatology and Child Health 377
  • Pharmacology 362
Replace Heather Boon with:
Heather Boon Canada
Philip C Hannaford United Kingdom
Alison L Jones United Kingdom
Martin R. Tramèr Switzerland
Richard A. Hansen United States
George Lewith United Kingdom
Ulf Bergman Sweden
Sue Jordan United Kingdom
Michael Weintraub United States
Hedvig Nordeng Norway
Andrew Herxheimer relative to Heather Boon Canada Heather Boon's profile →
Citations per field
00.5×1.5×
Heather Boon · 1×
Citations per year

Countries citing papers authored by Andrew Herxheimer

Since Specialization
Citations

This map shows the geographic impact of Andrew Herxheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Herxheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Herxheimer more than expected).

Fields of papers citing papers by Andrew Herxheimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Herxheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Herxheimer. The network helps show where Andrew Herxheimer may publish in the future.

Co-authorship network of co-authors of Andrew Herxheimer

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Herxheimer. A scholar is included among the top collaborators of Andrew Herxheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Herxheimer. Andrew Herxheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 56
2 44
3
A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine
57
4 6
5
The contribution of consumers and patients to clinical research.
2
6 6
7 12
8 3
9 91
10 39
11 2
12 13
13 2
14 2
15 43
16 11
17 11
18 65
19 123
20 6

About Andrew Herxheimer

Andrew Herxheimer is a scholar working on Geriatrics and Gerontology, Toxicology and Pharmacology, having authored 156 papers that have together received 3.5k indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (16 papers), Pharmaceutical Economics and Policy (14 papers) and Pharmaceutical Practices and Patient Outcomes (12 papers). The work is most often cited by research in Medical Terminology (23 citations), Toxicology (174 citations) and Pharmacology (362 citations). Andrew Herxheimer has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Keith J. Petrie, Sue Ziébland, H. E. de Wardener, Alison Chapple, N. D. W. Lionel, Yoon K. Loke, Deirdre Price, D M Chaput de Saintonge, Ann McPherson and Charles Medawar. Their work appears in journals such as Nature, The Lancet and The Journal of Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026